Quinner Baltazar
About Quinner Baltazar
Quinner Baltazar is an Associate Director at SalioGen Therapeutics with over 15 years of experience in the biotech industry, focusing on RNA/DNA and small molecules drug development. He has held various roles in established companies and start-ups, including positions at Moderna Therapeutics and Cogent Biosciences.
Work at SalioGen Therapeutics
Quinner Baltazar serves as Associate Director at SalioGen Therapeutics, a position he has held since 2021. In this role, he contributes to the development of innovative therapies, focusing on RNA and DNA technologies. His responsibilities include overseeing analytical development processes and ensuring compliance with regulatory standards. SalioGen Therapeutics is known for its commitment to advancing genetic medicine, and Baltazar's expertise plays a crucial role in the company's mission.
Previous Experience in Biotech and Pharmaceuticals
Quinner Baltazar has extensive experience in the biotech and pharmaceutical sectors, having held various positions across multiple companies. He worked as a Senior Manager in Analytical Development at Moderna Therapeutics from 2016 to 2020, where he contributed to the development of mRNA-based therapies. Prior to that, he served as Associate Director at Cogent Biosciences for one year in 2020. His career also includes roles at Vertex Pharmaceuticals and Alkermes, where he focused on analytical development and research.
Education and Expertise
Quinner Baltazar holds a Master's Degree in Analytical Chemistry from The University of Toledo, which he obtained from 2005 to 2007. He also earned a Bachelor's Degree in Chemistry from the University of San Carlos between 1997 and 2001. His educational background provides a solid foundation for his over 15 years of experience in drug development, particularly in RNA/DNA and small molecules. Baltazar has a strong background in analytical development, having started as a method development and QC scientist.
Career Progression and Roles
Baltazar's career began as a Research Chemist at Analytical Research Labs from 2008 to 2009. He then transitioned to Qualitest Pharmaceuticals as a Validation Chemist for one year in 2009. His role as a Senior Research Associate at Vertex Pharmaceuticals lasted from 2010 to 2013, followed by a position as Scientist II at Alkermes until 2016. He also served as CEO of MyCyberGenie for one year in 2015. His diverse roles reflect a progressive career in both start-ups and established companies.
Background in Analytical Development
Quinner Baltazar has a strong background in analytical development, which includes hands-on experience in method development and quality control within the generic pharmaceutical sector. He has led analytical teams through various stages of drug development, from pre-clinical and clinical phases to NDA and BLA submissions. His expertise in this area is critical for ensuring the efficacy and safety of pharmaceutical products.